Brandname clearance limit for drug products

Ask AI

BFAD MEMORANDUM CIRCULAR 16-A: Brandname clearance limit for drug products

What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

New Chat Started

Ask AI

Title Source: Supreme Court: Brandname clearance limit for drug products

Law: Bfad (doh) Memorandum Circular 16-a

Decision Date: Jul 15, 1994

The BFAD (DOH) Memorandum Circular 16-A, issued on July 15, 1994, mandates that applications for brandname clearance of a drug or pharmaceutical specialty may only propose five names, streamlining the evaluation process by disallowing further assessment of names if one has already been approved.

END